aculife healthcare 1 firm remarks: may be...

S No FirmsItem

CodeSpecification Item Remarks Status

1ACULIFE HEALTHCARE

PRIVATE LIMITED

1 95

Ciprofloxacin Injection IP 200mg/100ml BFS /

FFS May be considered

2 224

Dextrose with Sodium Chloride Injection 5% +

0.9% IP in 500ml IV BFS / FFS May be considered

3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered

The firm has not submitted the product approval May not be

Statement showing the Firm wise Technical Bid Evaluation Report for General Medicines

Tender Notice No: 60(20-21)/APMSIDC/Medicine Wing/2020-22, Dated: 03.06.2020

Firm Remarks: May be Considered

4 655 Water for Injection IP 10 ml amp

The firm has not submitted the product approval

for this product.

May not be

considered

5 1304 Lipids I.V. 20% In 250ml Bottles May be considered

6 1639

Mannitol 20% I.V. Infusion IP 100ml bottle

BFS/FFS May be considered

7 1676

Hydroxyethyl starch BP ( Hetastarch) with 450K

dalton/Tetra starch Hydroxyethyl starch 130K

dalton molecular weight May be considered

8 2119

Paracetamol Solution for Infusion (10mg/ml) in

100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered

9 2262 Dextrose 10% I.V 500 ml May be considered

2 ADHISH INDUSTRIES

1 1366 Chlorine Tablets 0.5gm May be considered

Firm Remarks: Avg turn over is less then as per tender hence May not be considered. And NCC certificate not submitted.

1 1366 Chlorine Tablets 0.5gm May be considered

3ADLEYFORMULATION

SPVTLTD

1 1220 Doxorubicin Injection IP 10 mg / 5 ml May be considered

2 1267 Cisplatin Injection IP 10 mg / 10 ml vial May be considered

3 1799 Etoposide Injection 100 mg / 5 ml vial May be considered

Firm Remarks: Firm may be considered after submission of Shelf life details of the all quoted products.

of 78

S No FirmsItem


4 1907 Paclitaxel Injection IP 30 mg / 5 ml May be considered

5 2098 Imatinib Mesylate Tab 400mg(Addl. Indication) May be considered

6 2227 Calcium Leucovorin Injection 50mg/ 5 ml vial May be considered

7 2233 Carboplatin 150mg /15 ml Injection Vial May be considered

8 2234 Carboplatin 450mg / 45 ml Injection Vial May be considered

9 2242 Cisplatin Injection IP 50 mg / 10 ml vial

May not be considered as the

specification/Strength is not matched

May not be

considered9 2242 Cisplatin Injection IP 50 mg / 10 ml vial specification/Strength is not matched considered

10 2269

Docetaxel 20mg/5ml or 20 mg/0.5 ml fill volume

in 5 ml vial May be considered

11 2270 Docetaxel 80mg/ 2 ml vial May be considered

12 2276

Each 20ml of reconstituted suspension contains:

Paclitaxel, USP-100mg Albumin Human USP-900

mg



May not be

considered

13 2279 Erlotinib Tablets 150mg May be considered

14 2300 Gemcitabine 200mg Injection vial May be considered

15 2305 Hydroxy Urea Capsules 500mg May be considered

16 2372 Oxaliplatin 100mg Injection vial May be considered


18 2374 Paclitaxel Injection 260mg vial May be considered

4 ADMAC LIFESCIENCES


2 1267 Cisplatin Injection IP 10 mg / 10 ml vial

May be considered after submission of valid

product approval as per tender requirement.

May not be

considered


of 78

S No FirmsItem


3 1799 Etoposide Injection 100 mg / 5 ml vial May be considered


5 2098 Imatinib Mesylate Tab 400mg(Addl. Indication) May be considered



8 2242 Cisplatin Injection IP 50 mg / 10 ml vial May be considered8 2242 Cisplatin Injection IP 50 mg / 10 ml vial May be considered

9 2269




11 2279 Erlotinib Tablets 150mg May be considered





5

Adroit

Pharmaceuticals Pvt Firm Remarks: May be Considered5 Pharmaceuticals Pvt

Limited

1 193 Dicyclomine Hcl Tablets 10 mg May be considered

2 279 Folic Acid Tablets 5mg May be considered

3 285 Formaldehyde Solution 500ml bottle



May not be

considered

4 311

Gamma Benzene Hexachloride Lotion 1% in 60ml

bottle May be considered


of 78

S No FirmsItem


5 475

Miconazole Nitrate Cream IP 2% 30gm tube -

Cream May be considered

6 525 Paracetamol Tablets IP 500 mg May be considered

7 1137 Domperidone Tablets IP 10 mg May be considered

8 1162 Loperamide Tablets 2mg May be considered

9 1177 Hydrogen Peroxide Solution IP 6% in 200ml



May not be

considered

10 1521 Primaquine Tablets IP 2.5 mg May be considered10 1521 Primaquine Tablets IP 2.5 mg May be considered

11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered

12 1636 Isoxsuprine Hcl Tablets 10 mg May be considered

13 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered

14 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered

15 1665 Glycerin IP 450gm May be considered

16 1701

Paracetamol Syrup IP (Non Alcohol based) 125 mg

/ 5 ml in 60ml May be considered

17 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered

6

Akums Drugs &

pharmaceuticals Firm Remarks: May be Considered6 pharmaceuticals

Limited

1 95




3 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg May be considered

4 1151

Domperidone Suspension IP 1 mg / ml in 30ml



of 78

S No FirmsItem


5 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered

6 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml May be considered

7 1639




9 1650 Permethrin Cream 5% 30gms tube May be considered

10 1678 Methyl Cobalamin Tablets 500mcg May be considered10 1678 Methyl Cobalamin Tablets 500mcg May be considered

11 1699 Azithromycin Dispersible Tablet 100 Mg May be considered

12 1700 Meropenam Injection IP 1gm vial May be considered

13 1865 Mefenamic Acid Tablets BP 500 mg May be considered

14 1970 Tranexamic acid Tablets BP 250mg May be considered

15 2073 Citicoline Tab 500mg May be considered

16 2113 Montelukast Tab 10mg May be considered

17 2119



18 2217 Betahistine Tablets IP 16 mg May be considered

19 2325 Levofloxacin Tablet 500 mg May be considered


21 2352

Natural Progesterone Injection 100mg/2 ml 2ml

Ampule May be considered

22 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered

of 78

S No FirmsItem


23 2398 Quetiapine 50mg Tablet May be considered

24 2437 Trypsin and Chymotrypsin Tablets 10 mg May be considered

7

ALCON

LABORATORIES INDIA

PRIVATE LIMITED

1 2304

Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%

in 10 ml May be considered

8Alpa Laboratories

Limited


Firm Remarks: May be Considered8Limited

1 527.01 Paracetamol Injection 300mg in 2ml

May be considered after submission of latest

product validity license

May not be

considered


3 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp



May not be

considered

4 1700 Meropenam Injection IP 1gm vial



May not be

considered

5 2066 Atropine sulphate injection 0.6%, 10ml vials



May not be

considered


9ANGLIFESCIENCES I

PVT LTD

1 664 Thiopentone Sodium Injection IP 0.5gm /ml May be considered




2 1310

Methyl Prednesolone Sodium Succinate Injection

USP 500 mg May be considered

3 1479 Acyclovir Injection 250mg May be considered



of 78

S No FirmsItem


10Appasamy Ocular

Devices (P) Ltd.

1 1372 Tropicamide+ phenylephrine 5 ml Eye drops May be considered

2 1377 Flurbiprofen Eye drops BP 0.03% 5 ml May be considered

3 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial May be considered

4 1742

Balanced Salt Solution Ophthalmic Solution 500

ml Pouch May be considered

5 1905 Olopatadine eye drops 0.1%w/v May be considered



6 1967 Tobramycin Eye drops 0.3% in 5 ml vial May be considered

7 2255 Cyclo Pentolate Eye drops 1% 5ml May be considered

8 2304



9 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial May be considered

10 2389 Povidone Iodine Eye Drops 5%, 5ml Vial May be considered

11 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml May be considered

11ARCO LIFESCIENCES

INDIA PVT LTD

1 107

Chloroquine Phosphate Injection IP 40 mg / ml in

3ml amp May be considered


1 107 3ml amp May be considered

2 209

Dopamine Hcl Injection IP 200mg in 5ml vial and

ampoule

May be considered after clarification of strength.

Submitted product approval for 40mg/ml whereas

in tender asked for 200mg/5ml

May not be

considered

3 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered

4 714

Menadione Sodium Bisulphate Inj 10mg/ml 1ml

Amp USP May be considered

of 78

S No FirmsItem


5 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml


Submitted product approval for 50mg whereas in

tender asked for 100mg/ml

May not be

considered

6 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered

7 2066 Atropine sulphate injection 0.6%, 10ml vials May be considered

8 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered

9 2319

Ketorolac Tromethamine Injection 30mg /ml, 1 ml

Ampoule May be considered

10 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules


Submitted product approval for 2mg whereas in

tender asked for 1mg/ml,2ml.

May not be

considered

11 2388

Potassium Chloride Injection 150mg/ml,10ml


12

ATRA

PHARMACEUTICALS

LIMITED

1 106

Chloroquine Phosphate Tablets IP 250 mg

base(Equivalent to 155 mg of Chloroquine ) May be considered


3 1470 Oseltamivir Cap 75mg May be considered




13 Aurolab

1 1372 Tropicamide+ phenylephrine 5 ml Eye drops

Bidder has submitted retension certificate of Form

28 valid upto 10-12-2022. May be considered

after submission of latest product approval list.

May not be

considered

2 1377 Flurbiprofen Eye drops BP 0.03% 5 ml




May not be

considered


of 78

S No FirmsItem


3 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial




May not be

considered

4 1683

Triamcinalone acetate Injection IP 40mg/ml 1ml

vial




May not be

considered

5 1819 Homatropine eye Drops IP 2% 5 ml




May not be

considered5 1819 Homatropine eye Drops IP 2% 5 ml after submission of latest product approval list. considered

6 1948

Silicon Oil Injection 1000mm 2/5 (cst) Injection

10ml Vial

Not submitted Approved product list hence May

not be considered

May not be

considered

7 2255 Cyclo Pentolate Eye drops 1% 5ml




May not be

considered

8 2389 Povidone Iodine Eye Drops 5%, 5ml Vial




May not be

considered

9 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml




May not be

considered

14BAXALTA BIOSCIENCE

INDIA PVT LTDFirm Remarks: May be Considered14

INDIA PVT LTD

1 1367 Human Albumin Solution I.P. 20% in100 ml bottle May be considered

2 2208

Anti Inhibitor Coagulant Complex (Intravenous

Route) 500 IU vial May be considered

3 2250

Coagulation Factor VIII rF VIII ( Recombinant or

Freeze Dried ) 1000 IU May be considered


of 78

S No FirmsItem


4 2251

Coagulation Factor VIII rF VIII (Recombinant or

Freeze Dried) 1500 IU

The firm has registration till 30/9/2018 for this

strength, after that period applicant failed to

enclose latest approval.

May not be

considered

5 2252



15BAXTERINDIAPRIVATE

LIMITED

1 1742

Balanced Salt Solution Ophthalmic Solution 500

ml Pouch


product approval latest as per tender

requirement.

May not be

considered

16Bharat Serums And

Vaccines Ltd


Firm Remarks: May be Considered16Vaccines Ltd

1 632 Antisnake Venom Injection May be considered

17bharath parentals

limeted

1 8

Amoxicillin oral suspension IP 125 mg / 5 ml in

60ml May be considered

2 97

Cotrimaxazole Tabs. IP 160mg+800mg

(Trimethoprim+Sulphamethoxazole ) May be considered

3 192 Doxycycline HCL Capsule IP 100 mg May be considered

4 209


ampoule

Submitted dosage strength is of 40mg where as in

tender asked for 200mg.

May not be

considered





7 714




9 1218

Dobutamine Hcl For Injection USP 250mg / 20 ml

Vial

Submitted dosage strength is of 12.50mg where

as in tender asked for 250mg/20ml vial.

May not be

considered

10 1310



of 78

S No FirmsItem


11 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered

12 1338

Clopidogrel Bisulphate Tablets I.P. 75mg,(Film

coated) May be considered

13 1340

Amoxycillin 500mg + 125mg Potassium Clavulanic

Acid Tablets IP May be considered

14 1370

Vitamin A Paediatric retinol solution 100000 IU

per ml May be considered

15 1426 Clotrimazole Ear Drops 1% in 5ml vial

Submitted packing is 10ml whereas in tender

asked for 5ml vial.

May not be

considered

16 1521 Primaquine Tablets IP 2.5 mg May be considered16 1521 Primaquine Tablets IP 2.5 mg May be considered

17 1621 Cefixime Dispersible Tablets USP 100 mg As it is for Export purpose only

May not be

considered


19 1629 Fluconazole Tablets IP 200mg As it is for Export purpose only

May not be

considered

20 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle

Submitted dosage strength is of 10gm where as in

tender asked for 3.325gm.

May not be

considered



23 1701



24 1739 Atorvastatin Tablets IP 20mg May be considered

25 1903 Olanzapine Tablets 5 mg May be considered

26 1953 Sodium valporate Tablets IP 200mg May be considered



29 2069 Carbmazepine Tablets 200mg May be considered of 78

S No FirmsItem


30 2073 Citicoline Tab 500mg As it is for Export purpose only

May not be

considered

31 2080 Diclofenac Sodium Tablets 100mg SR As it is for Export purpose only

May not be

considered

32 2140 Sodium Valporate Tab 500mg May be considered

33 2227 Calcium Leucovorin Injection 50mg/ 5 ml vial

Submitted product strength is 10mg/ml whereas

in tender asked for 50mg/5ml

May not be

considered

34 2235

Cefixime oral suspension 100mg / 5ml in 60ml

Bottle As it is for Export purpose only

May not be

considered

35 2243 Clindamycin 1 % gel 30 gms May be considered35 2243 Clindamycin 1 % gel 30 gms May be considered


37 2293 Fluoxetine Capsule 20mg May be considered



40 2412 Rosuvastatin Calcium 20 mg Tablet As it is for Export purpose only

May not be

considered

41 2440 Zinc Sulphate Dispersible Tablet10mg As it is for Export purpose only

May not be

considered

18 Biological E. Limited


Japanese Encephalitis Vaccine, Inactivated


2 2318

Japanese Encephalitis Vaccine, Inactivated

(Absorbed, Human) IP 0.5ml vial May be considered

19

CADILA

PHARMACEUTICALS

LIMITED

1 97





of 78

S No FirmsItem


3 1151





Firm has no product license approval for this

strenght.

May not be

considered

6 1683


vial May be considered


8 2325 Levofloxacin Tablet 500 mg May be considered8 2325 Levofloxacin Tablet 500 mg May be considered

20

CENTURY

PHARMALABS INIDA

PRIVATE LIMITED

1 475





4 2243 Clindamycin 1 % gel 30 gms May be considered

5 2244

Clindamycin 1% w/w + Benzoyl Peroxide 2.5 w/w

15 gms May be considered

21CIAN HEALTHCARE

LIMITED

May be considered after submission of latest May not be



1 192 Doxycycline HCL Capsule IP 100 mg


product approval

May not be

considered

2 197

Diclofenac Sodium 50mg Tablets IP (Enteric coated

Tablets) May be considered

3 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered

4 265 Furosemide Tablets IP 40mg May be considered


of 78

S No FirmsItem



7 1134 Risperidone Tablets USP 2 mg May be considered



10 1254 Spironolactone Tablets IP 25 mg, May be considered

11 1317 Ondansetron Tablets IP 4 mg May be considered11 1317 Ondansetron Tablets IP 4 mg May be considered


13 1338



14 1629 Fluconazole Tablets IP 200mg May be considered


16 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be considered




20 1691 Aciclovir Tablets IP 400 mg May be considered


22 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered

23 1734 Allopurinol Tablets IP 100 mg May be considered

24 1739 Atorvastatin Tablets IP 20mg May be considered of 78

S No FirmsItem


25 1794 Escitalopram Tablets 10mg May be considered

26 1808 Flunarazine Tablets 5mg May be considered

27 1855 Levamisole Tablets IP 150mg May be considered


29 1866 Mefloquine Hcl IP Tablets 250mg May be considered

30 1903 Olanzapine Tablets 5 mg May be considered30 1903 Olanzapine Tablets 5 mg May be considered

31 1970 Tranexamic acid Tablets BP 250mg May be considered




35 2125 Prazosin Tab 5mg May be considered

36 2126 Pregabalin SR Tablet 75mg May be considered

37 2163 Verapamil Tab 40mg May be considered

38 2164 Verapamil Tab 80mg May be considered

39 2205 Amitriptyline Tablets 25mg May be considered


41 2258 Deflozocort Tablets 6mg May be considered

42 2271 Donepezil Tablets 5mg May be considered

43 2281 Escitalopram Tablets 5mg May be considered of 78

S No FirmsItem


44 2292 Flunarizine Tablets 10mg May be considered


46 2313 Isosorbide Dinitrate Tablets 10mg May be considered

47 2316 Itraconazole Capsule 100 mg May be considered

48 2317 Ivermectin Tablets USP 6mg May be considered

49 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered49 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered

50 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered


52 2339 Mebeverine Hydrochloride IP 135mg Tablet May be considered

53 2412 Rosuvastatin Calcium 20 mg Tablet May be considered

54 2483 CilnidipineTab 20mg May be considered

55 2484 Prazocin Tab 1mg May be considered

56 2494 Chlorthalidone Tab 6.25mg May be considered

22Concord Biotech

LimitedFirm Remarks: May be Considered

1 1888 Mycophenolate mofetil Tab 500mg May be considered

2 1959 Tacrolimus Capsules 1mg May be considered

23 Coral Laboratories Ltd

1 37 Atenolol Tablets IP 50mg

May be considered after submission of latest valid

product license

May not be

considered

2 97


(Trimethoprim+Sulphamethoxazole )


product license

May not be

considered

Firm Remarks: May be considered after submission of valid product approval license for form-25 and Annexure-VIII with full address

of 78

S No FirmsItem


3 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg


product license

May not be

considered

4 106


base(Equivalent to 155 mg of Chloroquine )


product license

May not be

considered

5 192 Doxycycline HCL Capsule IP 100 mg


product license

May not be

considered

6 193 Dicyclomine Hcl Tablets 10 mg


product license

May not be

considered

7 197


Tablets)


product license

May not be

considered

8 207 Diltiazem Tablets IP 30 mg


product license

May not be

considered8 207 Diltiazem Tablets IP 30 mg product license considered

9 251 Enalapril Maleate Tablets IP 5mg


product license

May not be

considered

10 265 Furosemide Tablets IP 40mg


product license

May not be

considered

11 279 Folic Acid Tablets 5mg


product license

May not be

considered

12 482 Norfloxacin Tablets IP 400mg


product license

May not be

considered

13 525 Paracetamol Tablets IP 500 mg


product license

May not be

considered

14 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml


product license

May not be

considered

15 577 Prednesolone Tab 10mg


product license

May not be

considered

16 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg


product license

May not be

considered

17 1137 Domperidone Tablets IP 10 mg


product license

May not be

considered

18 1151


bottle


product license

May not be

considered

19 1254 Spironolactone Tablets IP 25 mg,


product license

May not be

considered

20 1319 Pantaprazole (Enteric Coated) Tablets 40mg


product license

May not be

considered

21 1338


coated)


product license

May not be

considered of 78

S No FirmsItem


22 1340


Acid Tablets IP


product license

May not be

considered

23 1438

Levothyroxine Tablets IP 100 micrograms(un

coated)


product license

May not be

considered

24 1701


/ 5 ml in 60ml Produced product approval for syrup

May not be

considered

25 1705 Alprazolam Tablets IP 0.5 mg


product license

May not be

considered

26 1734 Allopurinol Tablets IP 100 mg


product license

May not be

considered

27 1739 Atorvastatin Tablets IP 20mg


product license

May not be

considered27 1739 Atorvastatin Tablets IP 20mg product license considered

28 1903 Olanzapine Tablets 5 mg


product license

May not be

considered

29 2062 Acetyl Salicylic acid Tablets IP 75mg


product license

May not be

considered

30 2069 Carbmazepine Tablets 200mg


product license

May not be

considered

31 2080 Diclofenac Sodium Tablets 100mg SR


product license

May not be

considered

32 2111 Levothyroxine Tablets 50mcg


product license

May not be

considered

33 2325 Levofloxacin Tablet 500 mg


product license

May not be

considered

24Cyano Pharma Private

Limited

1 197


Tablets)


product license.

May not be

considered

Firm Remarks: May be considered after submission of Product License validity and latest product approval list.

1 197 Tablets) product license. considered



product license.

May not be

considered

3 311


bottle


product license.

May not be

considered

4 475


Cream


product license.

May not be

considered

5 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml


product license.

May not be

considered

6 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream


product license.

May not be

considered of 78

S No FirmsItem


7 1653 Povidone Iodine Ointment USP IP 5%, 100gm


product license.

May not be

considered



product license.

May not be

considered



product license.

May not be

considered

10 2440 Zinc Sulphate Dispersible Tablet10mg



May not be

considered

25

Daffodills

Pharmaceticals

LimitedCotrimaxazole Tabs. IP 160mg+800mg


1 97



2 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered


4 197



5 209


ampoule May be considered

6 211 Etophylline 77mg + Theophylline 23mg Tablets IP May be considered




9 311



10 475



11 482 Norfloxacin Tablets IP 400mg May be considered


13 527.01 Paracetamol Injection 300mg in 2ml May be considered

of 78

S No FirmsItem


14 714


Amp USP Firm has not submitted the product approval

May not be

considered

15 753 Povidone Iodine Solution 5% , 500ml bottle May be considered



18 1426 Clotrimazole Ear Drops 1% in 5ml vial May be considered


May be considered after submission of 10ml

product approval.

May not be

considered19 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml product approval. considered

20 1462 Ethamsylate Injection125mg/ml 2 ml ampoule May be considered


22 1623 Chloramphenicol Ear drops IP 5ml May be considered

23 1626

Chlorpheniramine Maleate Syrup 2 mg / 5ml in

60ml bottle May be considered





28 1700 Meropenam Injection IP 1gm vial Firm has not submitted the product approval

May not be

considered

29 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered



32 2316 Itraconazole Capsule 100 mg May be considered of 78

S No FirmsItem


33 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle Firm has not submitted the product approval

May not be

considered

34 2325 Levofloxacin Tablet 500 mg Firm has not submitted the product approval

May not be

considered

35 2383 Piperacillin + tazobactum Injection 2gm +0.25gm Firm has not submitted the product approval

May not be

considered

36 2388



26 Denis Chemlab ltd

1 95





2 224




4 2119



5 2212 Atropine sulphate injection 0.6%, 100ml vial


approved product license as per tender

requirement.

May not be

considered


27Drreddyslaboratoriesli

mited

1 251 Enalapril Maleate Tablets IP 5mg May be considered



2 1338




4 1930 Ramipril Tablets IP 5mg

Submitted product approval is for Capsules where

as in tender asked for tablets. May be considered

after clarification.

May not be

considered


of 78

S No FirmsItem


6 2319



7 2339 Mebeverine Hydrochloride IP 135mg Tablet May be considered

8 2342 Mesalazine Tablet 1.2 gm May be considered

28DUEFUL HEALTHCARE

PVT LTD




29

EMCURE

PHARMACEUTICALS

LIMITED



30ESKAG PHARMA PVT

LTD


May not be considered as the composition is not

matched as per the tender requirement.

May not be

considered

31FARISTA VANIJYA

PRIVATE LIMITED


Firm Remarks: May be cosidered after submission of Drug Manufacturing license( Whole Copy)

Firm Remarks: May be considered after submission of Valid NCC certificate (not older then 6 months), Valid GMP/WHO-GMP

certificate and list of latest valid approved product licenses.


1 95 FFS May be considered

2 224


0.9% IP in 500ml IV BFS / FFS



May not be

considered


4 1639



of 78

S No FirmsItem


32

FINECURE

PHARMACEUTICALS

LIMTED

1 1340





33FRESENIUS KABI

INDIA PVT LTD




2 1676

Hydroxyethyl starch BP ( Hetastarch) with 450K

dalton/Tetra starch Hydroxyethyl starch 130K

dalton molecular weight May be considered

3 2119



34FRESENIUS KABI

ONCOLOGY LIMITED






5 2269




7 2276

Each 20ml of reconstituted suspension contains:

Paclitaxel, USP-100mg Albumin Human USP-900

mg

The firm failed to produce product approval for

this product.

May not be

considered

of 78

S No FirmsItem






35Genetek Lifesciences

Pvt Ltd

1 655 Water for Injection IP 10 ml amp May be considered

Firm Remarks: May be considered after submission of Annexure VIII. All the required documents are not in order and not satisfactory.

Specified volume license for item code 2066 and 2388.




May be considered after submission of specified

volume licenses for the item as per the tender

requirement

May not be

considered

4 2388


Ampoule

May be considered after submission of specified

volume licenses for the item as per the tender

requirement

May not be

considered

36

GENNOVA

BIOPHARMACEUTICAL

S LIMITED

1 1966 Tissue plasminogen activator TPA 40mg May be considered

37Glenmark

Pharmaceuticals Ltd



1 1389 Clotrimazole Pessaries IP 100 mg May be considered

2 2289 Flucinolone Acetonide 0.1% w/w cream 30 gm May be considered

3 2290 Flucinolone Acetonide 0.01% w/w Lotion 30 ml May be considered



of 78

S No FirmsItem


6 2334

Liquid Paraffin 3.75 ml + milk of Magnesia 11.25

ml each 15 ml contain 170 ml bottle Syrup May be considered


8 2418 Sertaconazole Nitrate (Pessaries) 500 mg Tablet May be considered

9 2419

Sertaconazole Nitrate BP 2% w/v Propylene Glycol

base q.s. Pack -Bottle of 15 ml May be considered

10 2420


base q.s. Pack -Tube of 15 gms May be considered

38Grifols India Firm Remarks: May be considered after submission of valid manufacturing license (Certificate of manufacturing company of foreign

38Grifols India

Healthcare Pvt Ltd


2 2252



39 HEALERS LAB

1 37 Atenolol Tablets IP 50mg

May be considered if valid product approval is

produced. Firm submitted product approval valid

upto 24-03-2020. but not retained.

May not be

considered

2 197







May not be

considered

Firm Remarks: May be considered after submission of valid manufacturing license (Certificate of manufacturing company of foreign

company) and valid Annexure VIII.

Firm Remarks: May be considered after submission of latest product approvals for all products.

3 279 Folic Acid Tablets 5mg upto 24-03-2020. but not retained. considered


5 525 Paracetamol Tablets IP 500 mg




May not be

considered

of 78

S No FirmsItem


6 1134 Risperidone Tablets USP 2 mg




May not be

considered

7 1319 Pantaprazole (Enteric Coated) Tablets 40mg




May not be

considered

8 1338




9 1678 Methyl Cobalamin Tablets 500mcg




May not be

considered





May not be

considered

11 1794 Escitalopram Tablets 10mg




May not be

considered





May not be

considered


13 2073 Citicoline Tab 500mg




May not be

considered

14 2297 Gabapentin Tablets 300mg




May not be

considered





May not be

considered of 78

S No FirmsItem






May not be

considered

40

HEALTHY LIFE

PHARMA PRIVATE

LIMITED

1 193 Dicyclomine Hcl Tablets 10 mg May be considered


Firm Remarks: 1)May be considered after submission of Annexure II, Authorization letter nominating reponsible person with complete

details such as father name and intial with correct tender No. and Valid GMP certificate, Annexure VIII, XIII.


4 577 Prednesolone Tab 10mg Item is not in the product approval list

May not be

considered

5 1134 Risperidone Tablets USP 2 mg Item is not in the product approval list

May not be

considered


7 1389 Clotrimazole Pessaries IP 100 mg Item is not in the product approval list

May not be

considered

8 1438


coated) Item is not in the product approval list

May not be

considered

9 1492 Prednesolone Tab 20mg Item is not in the product approval list

May not be

considered

10 1522 ACT Kit for Adults Item is not in the product approval list

May not be

considered

May not be

11 1523 ACT Kit for (9-14 years) Item Strength not mentioned

May not be

considered

12 1525 ACT Kit for (1-4 years) Item Strength not mentioned

May not be

considered

13 1526 ACT Kit for (0-1 years) Item is not in the product approval list

May not be

considered


15 1975 Warfarin sodium Tablets IP 5 mg May be considered

of 78

S No FirmsItem


16 2111 Levothyroxine Tablets 50mcg May be considered


18 2313 Isosorbide Dinitrate Tablets 10mg Item is not in the product approval list

May not be

considered

19 2327 Levothyroxine Tablets 25mcg Item is not in the product approval list

May not be

considered

20 2343 Methyl Prednisolone IP 4mg Tablet Item is not in the product approval list

May not be

considered

21 2344 Methyl Prednisolone IP 8mg Tablet Item is not in the product approval list

May not be

considered21 2344 Methyl Prednisolone IP 8mg Tablet Item is not in the product approval list considered

22 2393 Pyridoxine HCL CR Tab. 100mg Item is not in the product approval list

May not be

considered

23 2429 Spironolactone Tablets IP 50 mg May be considered

41Hindustan

Laboratories

1 1370



42INDIANA

OPHTALMICS


2 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial May be considered



Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months).



5 2255 Cyclo Pentolate Eye drops 1% 5ml May be considered

6 2304




of 78

S No FirmsItem


8 2423 Sodium Chloride Eye drops 5% 5ml May be considered


10 2475 Moxifloxacin + Prednisolone acetate Eye Drops May be considered

43 INDSWIFT LIMITED

1 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered

2 197








7 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml May be considered

8 577 Prednesolone Tab 10mg May be considered



11 1317 Ondansetron Tablets IP 4 mg May be considered


13 1370





of 78

S No FirmsItem


16 1701






44

INTAS

PHARMACEUTICALS

LTD.1 30 Acetazolamide Tablets IP 250 mg

Firm Remarks: May be considered after submission of valid GMP/WHO GMP certificate of license No M/717/2016

1 30 Acetazolamide Tablets IP 250 mg


May be considered after clarification of USP & IP

grade

May not be

considered



5 1746 Bupropion Hcl Tablets 150 mg USP

May be considered after clarification of USP & IP

grade

May not be

considered

6 1820 Human Immunoglobulin IV 5 gm/100ml May be considered

7 1866 Mefloquine Hcl IP Tablets 250mg May be considered


9 1906 Oxybutynin Tablets BP 2.5mg

May be considered after clarification of USP & BP

grade

May not be

considered9 1906 Oxybutynin Tablets BP 2.5mg grade considered

10 1930 Ramipril Tablets IP 5mg

Item is not considered as the dosage form is

different

May not be

considered




of 78

S No FirmsItem


14 2252



15 2269


in 5 ml vial

Item is not considered as the volume approval as

per licence was 1ml & 4ml but required in 5ml

vial

May not be

considered

16 2270 Docetaxel 80mg/ 2 ml vial

Item is not considered as the product approval is

for export only

May not be

considered




20 2297 Gabapentin Tablets 300mg May be considered

21 2340 Memantine 10mg Tablet May be considered

22 2382 Phenytoin sodium Tablets IP 300mg May be considered





45 INTERMED Firm Remarks: May be considered after submission of latest renewal certificate for all approved products produced.45 INTERMED

1 37 Atenolol Tablets IP 50mg May be considered

2 97




4 475




Firm Remarks: May be considered after submission of latest renewal certificate for all approved products produced.

of 78

S No FirmsItem







11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered


13 1682 Salicylic Acid Cream 5% , 30gms tube May be considered











24 2429 Spironolactone Tablets IP 50 mg May be considered of 78

S No FirmsItem


46JOHNSON AND SMITH

CO

1 40.02 Acetyl Salicylic Acid Tablets IP 150mg May be considered

2 97



3 197







6 285 Formaldehyde Solution 500ml bottle May be considered

7 311




9 513.01

Oral Rehydration Salts IP (ORS) 20.5gm WHO

formula with citrate salts May be considered




13 1137 Domperidone Tablets IP 10 mg May be considered13 1137 Domperidone Tablets IP 10 mg May be considered



16 1338




18 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered of 78

S No FirmsItem




21 1701




23 2062 Acetyl Salicylic acid Tablets IP 75mg May be considered

24 2065 Atorvastatin Tablets IP 10mg May be considered24 2065 Atorvastatin Tablets IP 10mg May be considered

25 2333 Liquid Paraffin 100 ml May be considered

26 2335 Liquid Paraffin 500ml May be considered



29 2375 Paraffin Wax 500 gms May be considered

47KONIS

PHARMACEUTICALS

1 107

Chloroquine Phosphate Injection IP 40 mg / ml in

3ml amp May be considered


Firm Remarks: May be considered after submission of latest NCC certificate (not older than 6months).






7 1752 Cefuroxime Injection IP 250 mg vial May be considered of 78

S No FirmsItem


8 2319



9 2330 Lignocaine Hydrochloride Injection I.P. 5% w/ v May be considered


48Lundbeck India

Private limited

1 2443

Zuclopenthixol (Acetate / Decanoate ) Injection I.P

50 mg May be considered

49M.J.BIOPHARM PVT.

LTD.,

Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months).

Firm Remarks: May be considered after submission of complete license.49LTD.,


50

MACLEODS

PHARMACEUTICALS

LTD



3 1145 Carbimazole Tablets 5mg May be considered





6 1340



7 1438


coated)

May be considered after submission of product

approval

May not be

considered

8 1621 Cefixime Dispersible Tablets USP 100 mg May be considered


10 1701



of 78

S No FirmsItem




13 1752 Cefuroxime Injection IP 250 mg vial May be considered

14 1930 Ramipril Tablets IP 5mg May be considered




approval

May not be

considered16 2111 Levothyroxine Tablets 50mcg approval considered



19 2231 Carbimazole Tablet 10mg May be considered


21 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered





approval

May not be

considered



27 2428 Spiramycin Tablet 3.0 M.I.U May be considered


51MALIK LIFESCIENCES

PRIVATE LIMITEDFirm Remarks: May be Considered

of 78

S No FirmsItem


1 8



2 1340




4 2235


Bottle May be considered

52MARC LABORATORIES

LTD

1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml


renewal/retention certificate

May not be

considered

Firm Remarks: May be considered after submission of complete license and latest retention/renewals certificate & submitting

Manufacturing unit address, Shelf life in Annexure-VIII.

1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml renewal/retention certificate considered

2 1621 Cefixime Dispersible Tablets USP 100 mg



May not be

considered




May not be

considered

4 1700 Meropenam Injection IP 1gm vial



May not be

considered

5 1701



6 2235



53MARS THERAPEUTICS

and CHEMICALS LTD




2 97



3 136 Carbmazepine Tablets (Film coated) 100mg May be considered




of 78

S No FirmsItem


7 1338



8 1953 Sodium valporate Tablets IP 200mg

May be considered after submission of approrval

for IP specification of the product

May not be

considered


10 2069 Carbmazepine Tablets 200mg May be considered

11 2287

Ferrous ascorbate equivalent to 50 mg Iron + Folic

acid 1.5 mg) tablet May be considered

12 2325 Levofloxacin Tablet 500 mg May be considered12 2325 Levofloxacin Tablet 500 mg May be considered


14 2440 Zinc Sulphate Dispersible Tablet10mg

May be considered after submission of approval

for Zinc Sulphate dispersable tablet.

May not be

considered

54MASCOT HEALTH

SERIES PVT LTD

1 8










7 1338




9 1621 Cefixime Dispersible Tablets USP 100 mg


approval

May not be

considered

10 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream The License is given for only export

May not be

considered of 78

S No FirmsItem







16 2113 Montelukast Tab 10mg May be considered16 2113 Montelukast Tab 10mg May be considered

17 2126 Pregabalin SR Tablet 75mg


approval

May not be

considered

18 2127

Pregabalin SR 75mg + Methylcobalamin 1500mcg

Tablets May be considered







25 2382 Phenytoin sodium Tablets IP 300mg May be considered



55MED MANOR

ORGANICS PVT LTD



of 78

S No FirmsItem


2 1650 Permethrin Cream 5% 30gms tube

May be considered after clarification of cream or

Gel as per requirement

May not be

considered





7 2419


base q.s. Pack -Bottle of 15 ml May be considered7 2419 base q.s. Pack -Bottle of 15 ml May be considered

8 2420


base q.s. Pack -Tube of 15 gms

May be considered after clarification of the

medium i.ePropylene glycol Base

May not be

considered

56Meridian Enterprises

Pvt Ltd



3 2219 Bisacodyl Suppositories 10mg May be considered

4 2264 Diclofenac Sodium suppositories 100 mg May be considered

57MSD Pharmaceuticals

Private Limited

Quadrivalent Human Pappiloma Virus Vaccine

Firm Remarks: May be considered after submission of valid latest NCC Certificate (not older than 6months), Authorisation letter

issued by Mg.Director responsible as per Annexure XIV and shelf life and Batch size details of porducts.

Firm Remarks: May be considered after submission of NCC Certificate (not older than 6months) and Annexure VIII

1 2395

Quadrivalent Human Pappiloma Virus Vaccine

Injection (0.5ml PFS) May be considered

58

NECTAR

LABORATORIES

PRIVATE LIMITED




of 78

S No FirmsItem


59

NOVARTIS

HEALTHCARE PRIVATE

LIMITED


60NOVO NORDISK INDIA

PVT LTD

1 2250



2 2251


Freeze Dried) 1500 IU May be considered


Firm Remarks: May be considered after submission of NCC Certificate (not older than 6months) and Annexure VIII

Firm Remarks: May be considered after submission of valid GMP/ WHO GMP Certificates.

3 2252



61

OTSUKA

PHARMACEUTICAL

INDIA PRIVATE

LIMITED

1 95



2 224








6 1639




62

Paviour

Pharmaceuticals Pvt.

Ltd.


Firm Remarks: May be considered after submission of Annexure VIII with Manfacturing unit Address

of 78

S No FirmsItem


2 2309

IgM enriched Immunoglobulin IgM 12%, IgG 76%

& IgA 12% concentrate 10ml May be considered

3 2386 Porcine Lung Surfactant 1.5 ml 120mg May be considered

4 2387 Porcine Lung Surfactant 3ml 240mg May be considered

63 Pentagon Labs ltd

1 95


FFS


renewal/retention certificate of products.

May not be

considered

2 224


0.9% IP in 500ml IV BFS / FFS



May not be

considered


Firm Remarks: May be considered

3 440 Metronidazole IV Infusion IP 500mg in 100 ml



May not be

considered

4 1639


BFS/FFS



May not be

considered

5 2119


100ml glass bottle i.e.1gm/100ml BFS/FFS



May not be

considered

6 2262 Dextrose 10% I.V 500 ml



May not be

considered

64 Pfizer Limited



Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months) and Annexure-II authorized by

Mg.Director of the firm and nominating a responsible person authorized by Mg.Director of the firm and Annexure-XIII authorized by

Mg.Director of the firm and Annexure-VIII authorized by Mg.Director of the firm.





6 2337 Lorazepam Tablet 2mg May be considered

of 78

S No FirmsItem


65PFIZER PRODUCTS

INDIA PVT LTD

1 1310



2 2203 Adriamycin Injection 50mg / 25ml vial


approval

May not be

considered






6 2250



7 2252



8 2343 Methyl Prednisolone IP 4mg Tablet May be considered


66

Pharma Impex

Laboratories Private

Limited

1 95



2 224



Firm Remarks: May be considered after submission of corrected Annexure-VIII


4 1639





of 78

S No FirmsItem


7 2119




67

Premium Serums and

Vaccines Privated

Limited


68 PROTECH TELELINKS

Dopamine Hcl Injection IP 200mg in 5ml vial and May not be



1 209


ampoule in composition each ml contains Dobutamive Hcl

May not be

considered

2 1218


Vial May be considered

3 1310




5 1455 Betaxolol eye Drops 0.25%, 5 ml May be considered


7 1683



8 1694 Labetalol Hcl Injection IP 5mg / ml in 10ml vial May be considered






of 78

S No FirmsItem



15 2425 Sodium Valporate Injection 500mg / 5ml Vial May be considered

16 2432 Thiamine Injection 100mg / ml vial 2 ml May be considered


69

PULSE

PHARMACEUTICALS

PRIVATE LIMITEDClopidogrel Bisulphate Tablets I.P. 75mg,(Film


1 1338



2 1678 Methyl Cobalamin Tablets 500mcg May be considered

3 1701









70

PURE AND CURE

HEALTHCARE PRIVATE

LIMITED


2 197




of 78

S No FirmsItem







8 1317 Ondansetron Tablets IP 4 mg May be considered8 1317 Ondansetron Tablets IP 4 mg May be considered


10 1338




12 1705 Alprazolam Tablets IP 0.5 mg May be considered






18 2080 Diclofenac Sodium Tablets 100mg SR May be considered


20 2127



21 2140 Sodium Valporate Tab 500mg May be considered of 78

S No FirmsItem







27 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered27 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered

71

Rathnam

pharmaceuticals pvt

ltd


2 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg


product approval list.

May not be

considered




May not be

considered

4 513.01


formula with citrate salts



May not be

considered

5 1338


coated)



May not be

considered

6 1701


/ 5 ml in 60ml



May not be

considered


Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months) and Authorization letter of

nominating responsible person and valid GMP/WHO-GMP Certificate and All Products approval licenses.

7 2126 Pregabalin SR Tablet 75mg



May not be

considered




May not be

considered

72Reliance life sciences

pvt ltd




of 78

S No FirmsItem


3 1966 Tissue plasminogen activator TPA 40mg May be considered

4 2252



73REVAT LABORATORIES

PRIVATE LIMITED





3 97




5 106







10 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered


11 1151



12 1370




14 1626




of 78

S No FirmsItem



17 1643

Metronidazole benzoate Oral Suspention IP

100mg/5ml in 60ml May be considered


19 1701




21 1713 IFA syrup May be considered21 1713 IFA syrup May be considered






74RIDLEY LIFE SCIENCE

PRIVATE LIMITED


2 311



Firm Remarks: May be considered after submission of valid NCC certificate of NW(0109)/MNB/17 and NW(110)/MNB/17 (Not older

than 6months) and submitted Annexure-VIII but not given the shelf life for applied products.

2 311 bottle May be considered

3 475





6 1151



7 1389 Clotrimazole Pessaries IP 100 mg May be considered of 78

S No FirmsItem


8 1625

Chloroquine Phosphate Syrup 50 mg / 5 ml in





product approval

May not be

considered

11 1643




13 1650 Permethrin Cream 5% 30gms tube May be considered13 1650 Permethrin Cream 5% 30gms tube May be considered


15 1701




17 1713 IFA syrup May be considered

18 2235



19 2236 Cefixime Oral Suspension 25mg/ml, 10ml Bottle May be considered



22 2290 Flucinolone Acetonide 0.01% w/w Lotion 30 ml May be considered




26 2419


base q.s. Pack -Bottle of 15 ml May be considered of 78

S No FirmsItem


27 2420



75RUSAN PHARMA

LIMITED

1 1804 Fentanyl Inj. 100mcg/2ml May be considered

2 1890 Naloxone HCL Injection USP 400mcg/ml, 1ml amp May be considered

3 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules item composition not tallied

May not be

considered

76 Sai Parenterals Pvt.Ltd

Firm Remarks: May be considered after submission of Autorization letter nominating a responsible person (Authoriazation given by

another authorized signatury, Who's authorization name not submitted.)

Firm Remarks: May be Considered76 Sai Parenterals Pvt.Ltd


2 1310






6 2432 Thiamine Injection 100mg / ml vial 2 ml May be considered

77

SALAS

PHARMACEUTICALS

PVT LTDMay be considered after submission of latest May not be




product approval

May not be

considered





of 78

S No FirmsItem





product approval

May not be

considered




11 2127


Tablets May be considered11 2127 Tablets May be considered


13 2217 Betahistine Tablets IP 16 mg


product approval

May not be

considered







product approval

May not be

considered

19 2368 Olanzapine Tablets 2.5mg


product approval

May not be

considered


78 SAMKEM

1 513.01





Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months)

of 78

S No FirmsItem


4 1151



5 1625




May be considered after submission of approval

for the strength 3.325gm/5ml

May not be

considered

7 1665 Glycerin IP 450gm


approval

May not be

considered

8 1701



9 2333 Liquid Paraffin 100 ml


approval

May not be

considered9 2333 Liquid Paraffin 100 ml approval considered

10 2335 Liquid Paraffin 500ml


approval

May not be

considered

11 2375 Paraffin Wax 500 gms


approval

May not be

considered

79Sandoz Private

Limited

1 2310

Indacaterol 110mcg+Glycopyrronium 50 mcg

Capsules+ inhaler May be considered

2 2416 Sacubutril + Valsartan film coated Tablet 50mg May be considered

80 Sanofi India Limited

1 2295 Framycetin Sulphate Cream 1% w/w 100gm tube May be considered

2 2296 Framycetin Sulphate Cream 1% w/w 30gm tube May be considered


Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months)

81 SEEKO BIOTICS


2 40 Ascorbic Acid Tablets IP (Chewable) 500 mg


product approval

May not be

considered

3 136 Carbmazepine Tablets (Film coated) 100mg


product approval

May not be

considered

Firm Remarks: All the Required documents are not in order and not satisfactory but firm may be considered after giving

proper/satisfactory explanation on arrangement of documents. Also not enclosed Annexure-II & Non-conviction certificate (not older

than 6months)

of 78

S No FirmsItem


4 197



5 207 Diltiazem Tablets IP 30 mg May be considered




9 482 Norfloxacin Tablets IP 400mg May be considered9 482 Norfloxacin Tablets IP 400mg May be considered






15 1521 Primaquine Tablets IP 2.5 mg May be considered





20 1808 Flunarazine Tablets 5mg


product approval

May not be

considered


22 1930 Ramipril Tablets IP 5mg May be considered of 78

S No FirmsItem






27 2127



28 2146 Carbimazole Tablets 20mg May be considered28 2146 Carbimazole Tablets 20mg May be considered




32 2292 Flunarizine Tablets 10mg


product approval

May not be

considered







82

SHINE

PHARMACEUTICALS

LTD



of 78

S No FirmsItem







7 1953 Sodium valporate Tablets IP 200mg May be considered7 1953 Sodium valporate Tablets IP 200mg May be considered




83Shree Anand Life

Sciences Ltd

1 209







6 1218




6 1218 Vial May be considered7 1479 Acyclovir Injection 250mg May be considered

8 1694 Labetalol Hcl Injection IP 5mg / ml in 10ml vial May be considered

9 2066 Atropine sulphate injection 0.6%, 10ml vials May be considered


11 2319


Ampoule May be considered12 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered

13 2388


Ampoule May be considered of 78

S No FirmsItem


14 2411 Ropivacaine Injection 0.75mg%, 10ml Vial May be considered

84

SM

PHARMACEUTICALS

PVT LTD

1 285 Formaldehyde Solution 500ml bottle


product approval

May not be

considered

2 311


bottle


product approval

May not be

considered

3 513.01






6 1151



7 1177 Hydrogen Peroxide Solution IP 6% in 200ml May be considered

8 1370


per ml


product approval

May not be

considered




product approval

May not be

considered

11 1701


/ 5 ml in 60ml

May be considered after clarification of Adult/

paediatric as the product approval is submitted

for paediatric

May not be

considered11 1701 / 5 ml in 60ml for paediatric considered

12 1713 IFA syrup


product approval

May not be

considered




product approval

May not be

considered



product approval

May not be

considered

of 78

S No FirmsItem


16 2375 Paraffin Wax 500 gms


product approval

May not be

considered

85

STALLION

LABORATORIES PVT

LTD


2 197




May be considered after submission of product May not be

Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months) and Annexure VIII (Shelf life not

produced).

4 482 Norfloxacin Tablets IP 400mg


approval

May not be

considered

5 513.01


formula with citrate salts


approval

May not be

considered



8 1338






approval

May not be

considered







approval

May not be

considered

16 2313 Isosorbide Dinitrate Tablets 10mg


approval

May not be

considered

of 78

S No FirmsItem


17 2316 Itraconazole Capsule 100 mg


approval

May not be

considered



approval

May not be

considered



approval

May not be

considered

86STRIDE ORGANICS

PVT LTD


2 97




2 97 (Trimethoprim+Sulphamethoxazole ) May be considered

3 106



4 197








10 1340


Acid Tablets IP May be considered10 1340 Acid Tablets IP May be considered


12 1626




14 1701



15 1713 IFA syrup May be considered

of 78

S No FirmsItem





19 2225

Calcium Citrate 1000 mg+ Vit. D3 200 I.U.

Methylcobalamin 500 mcg+ Folic Acid 5mg +

Pyridoxine Hcl 10 mg May be considered

20 2287

Ferrous ascorbate equivalent to 50 mg Iron + Folic

acid 1.5 mg) tablet May be considered

SUDARSHAN

87

SUDARSHAN

PHARMACEUTICALS

PVT LTD


2 197




4 513.01




88Super Formulations

Pvt. Ltd.






3 475




5 513.01



of 78

S No FirmsItem







11 2243 Clindamycin 1 % gel 30 gms May be considered11 2243 Clindamycin 1 % gel 30 gms May be considered



14 2420



89SWISS PARENTERALS

PVT. LTD.

1 209




3 1310






6 1683





of 78

S No FirmsItem


9 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered



90 Syndicate Pharma


2 475





3 513.01




5 1151



6 1625



7 1626




9 1643





12 1701




14 2280

Erythromycin Syp 60 ml ( each 5ml contains 125

mg) May be considered


of 78

S No FirmsItem


16 2420



91

Synokem

Pharmaceuticals

Limited










product license

May not be

considered

92SYSTOCHEM

LABORATORIES LTD

1 209




3 475





5 714




7 1218




of 78

S No FirmsItem





12 1682 Salicylic Acid Cream 5% , 30gms tube May be considered

13 1683



14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered


May be considered after clarification of regarding

pack size

May not be

considered


17 2244

Clindamycin 1% w/w + Benzoyl Peroxide 2.5 w/w

15 gms May be considered



20 2304



21 2319






25 2432 Thiamine Injection 100mg / ml vial 2 ml


valid product license with required strength

May not be

considered

93 TABLETS INDIA LTD

1 2119




of 78

S No FirmsItem


2 2385

Polyethylene glycon with elecrolytes for oral

solution 137.15 gms powder May be considered

94

THE

SWASTIKPHARMACEU

TICALS

1 311






Firm Remarks: May be considered after submission of valid GMP / WHO GMP Certificate.

4 1701



5 2333 Liquid Paraffin 100 ml May be considered

6 2335 Liquid Paraffin 500ml May be considered

95TRIVENI

FORMULATIONS LTD



3 1338










of 78

S No FirmsItem







96 Unicure India Pvt. Ltd. Firm Remarks: May be Considered

1 30 Acetazolamide Tablets IP 250 mg May be considered




5 97




7 106


base(Equivalent to 155 mg of Chloroquine )


product license

May not be

considered

8 192 Doxycycline HCL Capsule IP 100 mg May be considered8 192 Doxycycline HCL Capsule IP 100 mg May be considered

9 197




11 207 Diltiazem Tablets IP 30 mg May be considered


13 251 Enalapril Maleate Tablets IP 5mg May be considered of 78

S No FirmsItem




16 308 Griseofulvin Tablets IP 125 mg May be considered

17 311



18 475



19 482 Norfloxacin Tablets IP 400mg May be considered19 482 Norfloxacin Tablets IP 400mg May be considered

20 513.01











29 1151





32 1257 Tamoxifen Citrate Tablets IP 10 mg, May be considered of 78

S No FirmsItem




35 1338



36 1370




38 1438


coated) May be considered38 1438 coated) May be considered


40 1474

Sulfadoxine + Pyrimethamine 500 mg Sulfadoxine

+ 25 mg Pyrimethamine Tablets IP May be considered


42 1522 ACT Kit for Adults May be considered

43 1523 ACT Kit for (9-14 years)

May be considered after clarification of strength

for Artisunate is 150mg instead of 50mg

May not be

considered

44 1525 ACT Kit for (1-4 years) May be considered

45 1526 ACT Kit for (0-1 years) May be considered


47 1625





50 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be considered of 78

S No FirmsItem


51 1643







May be considered after submission of Re-Packing

product license for 500gm i.e.25B

May not be

considered

56 1669 Betahistine Tablets IP 8 mg May be considered56 1669 Betahistine Tablets IP 8 mg May be considered


58 1690

Carbmazepine Suspension USP 100mg/5ml, in




61 1701





64 1734 Allopurinol Tablets IP 100 mg May be considered


66 1754

Chlorbutol+ Bezoncaine+ Turpentine Oil+

Paradichloro Benzine Ear Drops


product license

May not be

considered



69 1846 Ivermectin Tablets USP 3mg May be considered of 78

S No FirmsItem


70 1855 Levamisole Tablets IP 150mg May be considered





75 1959 Tacrolimus Capsules 1mg May be considered75 1959 Tacrolimus Capsules 1mg May be considered

76 1971 Trimetazidine Tablets 20mg May be considered





81 2080 Diclofenac Sodium Tablets 100mg SR


product license

May not be

considered




85 2140 Sodium Valporate Tab 500mg May be considered



of 78

S No FirmsItem


88 2225



Pyridoxine Hcl 10 mg


product license

May not be

considered

89 2235



90 2238 Chlordiazepoxide Tablets 25mg May be considered









99 2317 Ivermectin Tablets USP 6mg May be considered





license in Form-25B

May not be

considered



license in Form-25B

May not be

considered

104 2337 Lorazepam Tablet 2mg May be considered

105 2343 Methyl Prednisolone IP 4mg Tablet


product license

May not be

considered

of 78

S No FirmsItem


106 2344 Methyl Prednisolone IP 8mg Tablet


product license

May not be

considered



109 2368 Olanzapine Tablets 2.5mg May be considered

110 2385

Polyethylene glycon with elecrolytes for oral

solution 137.15 gms powder May be considered

111 2397 Quetiapine 25mg Tablet May be considered111 2397 Quetiapine 25mg Tablet May be considered



114 2420




product license

May not be

considered

115 2429 Spironolactone Tablets IP 50 mg May be considered

116 2492 Sodium bicarbonateTab 500mg May be considered

97UNIMARCK

HEALTHCARE LIMITED


May be considered after obating clarification from



May be considered after obating clarification from

the firm as tender called for ondansetron tablets

IP 4mg only

May not be

considered




of 78

S No FirmsItem



7 1317 Ondansetron Tablets IP 4 mg

May be considered after clarification regarding the

formulation

May not be

considered


9 1338




11 1705 Alprazolam Tablets IP 0.5 mg May be considered11 1705 Alprazolam Tablets IP 0.5 mg May be considered


13 1754


Paradichloro Benzine Ear Drops May be considered

14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered




product license.

May not be

considered







23 2127



24 2205 Amitriptyline Tablets 25mg May be considered of 78

S No FirmsItem







30 2316 Itraconazole Capsule 100 mg May be considered30 2316 Itraconazole Capsule 100 mg May be considered

31 2319






35 2340 Memantine 10mg Tablet May be considered

36 2352

Natural Progesterone Injection 100mg/2 ml 2ml

Ampule May be considered

37 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial


product license.

May not be

considered

38 2368 Olanzapine Tablets 2.5mg


product license.

May not be

considered



41 2483 CilnidipineTab 20mg


product license.

May not be

considered

98

Vee Excel Drugs and

Pharmaceuticals

Private Ltd


of 78

S No FirmsItem


1 197







6 1338


coated) May be considered6 1338 coated) May be considered


8 1699 Azithromycin Dispersible Tablet 100 Mg


product license

May not be

considered


10 1953 Sodium valporate Tablets IP 200mg Submitted Export product License

May not be

considered

11 1971 Trimetazidine Tablets 20mg May be considered



14 2140 Sodium Valporate Tab 500mg


product license

May not be

considered


16 2235





19 2326 Levofloxacin Tablet 750 mg May be considered of 78

S No FirmsItem


20 2437 Trypsin and Chymotrypsin Tablets 10 mg

May be considered after clarification of product

licnese for 1,00,000 Armous units where as

tender called for 10mg

May not be

considered

99VERVE HUMAN CARE

LABORATORIES

1 1804 Fentanyl Inj. 100mcg/2ml May be considered

2 1890 Naloxone HCL Injection USP 400mcg/ml, 1ml amp May be considered




4 2379 Pethidine Hydrochloride Injection BP 50mg/ ml May be considered

100vins bio products

limited


101Virchow Biotech

Private Limited


102 Vivimed Labs Limited


2 475




Firm Remarks: May be considered after submission of valid NCC Certificate (Not older then 6 months) and submit Manufacturing

capacity in Annexure-VIII


2 475 Cream May be considered

3 1151


bottle May not be considered as the strength differ

May not be

considered

4 1372 Tropicamide+ phenylephrine 5 ml Eye drops

May be considered after clarification of volume of

vial/package/final container

May not be

considered


6 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial



May not be

considered

of 78

S No FirmsItem





May not be

considered

8 1754


Paradichloro Benzine Ear Drops May be considered


10 2225



Pyridoxine Hcl 10 mg May be considered

11 2304


in 10 ml



May not be

considered

May be considered after clarification of volume of May not be

12 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial



May not be

considered

13 2419


base q.s. Pack -Bottle of 15 ml



May not be

considered

14 2420





May not be

considered

103 ZEST PHARM

1 8




3 97




Firm Remarks: May be considered after submission of Authorization letter nominating a responsible person (Authorization is given to

a firm i.e Royal agencies instead of a person, further authorization given by authorized signature)


6 1522 ACT Kit for Adults May be considered




of 78

S No FirmsItem


10 2235




Note: All the bidders are here by requested to verify the Provisional Technical Evaluation Report and submit their supporting documents on or

before 12.00 P.M on 17.08.2020 to the email: [email protected] with Subject : Reply to T No 60(General Medicines) Preliminary TEC Report

of 78

aculife healthcare 1 firm remarks: may be...

Documents